New GILENYA OPPORTUNISTIC INFXN

[Anonymous]

Sorry, but there has been more than one case of toxo.

So what it's not PML. PML kills the patient with Toxo is home doing fine. Just Teva and Biogen running with anything they can to save their business

 

[Anonymous]

The culture of this company over the past 3 years has been perceived as one of silence, poor communication, and lack of transparency.

Does anyone truly thinks that Novarts is going to disclose all the relevant facts with regards to the various cases of opportunistic infections presenting in patients on Gilenya ?

That information is perhaps discussed behind close doors - Betsy, Trevor, and who knows what other conspirator - the facts are perhaps carefully massage, documents prepared, and endless correspondance and teleconferences with the FDA - all a very well orchestrated delay tactic, perhaps....while, the Salesforce drives prescriptions and revenues (who cares about the patients ? ....Mr Heinz ?)

They perhaps knew that the dose selected may have been too high - but that might have undermined the efficacy results in the pivotal studies and weaken the competitive stance of Gilenya vs the interferons. They perhaps knew that it would take a few years for OI to show...so they are perhaps banking that they are going to have data on the low dose study (if ever completed) - and then, re-negotiate with the FDA ...thus at the end, able to save their "blockbuster".

But at whose expense ?
The patients ? perhaps ?

Too bad whistleblowers, perhaps, will be executed.
Blood in the floor....won't be Heinz Ketchup.....Unfortunately...but perhaps, mine, yours and the patients.

"PERHAPS" this post has some truth behind it....the OP "perhaps" is close to the top...or "perhaps" close to the Ketchup, himself.